Citation Impact

Citing Papers

Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
The Classical Complement Pathway: Activation and Regulation of the First Complement Component
1985
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.
1990 Standout
A Human Homolog of Angiotensin-converting Enzyme
2000 Standout
Lipid rafts and signal transduction
2000 Standout
Rheumatoid arthritis
2016 Standout
In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density
2001
Genetic associations with human longevity at the APOE and ACE loci
1994 Standout
Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure
1992
Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis
2008
Primary Pulmonary Hypertension
1997 Standout
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
1992 StandoutNature
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice
2004 StandoutNobel
Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.
1994 Standout
A heteromeric Texas coral snake toxin targets acid-sensing ion channels to produce pain
2011 StandoutNatureNobel
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.
1997 StandoutNobel
Localization of angiotensin‐converting enzyme in the trout gill
1989
EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN
1989 Standout
Angiotensin-converting enzyme 2 protects from severe acute lung failure
2005 StandoutNature
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
1988 StandoutNature
Male–female differences in fertility and blood pressure in ACE-deficient mice
1995 StandoutNatureNobel
Pulmonary Endothelial Cell Pathobiology: Implications for Acute Lung Injury
1992
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Sarcoidosis
1997 Standout
Functional Genomic Analysis of C. elegans Molting
2005 StandoutNobel
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
2004 Standout
The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro
1988
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells
1999 StandoutNobel
Angiotensin-converting enzyme: new concepts concerning its biological role
1989
Spider toxins activate the capsaicin receptor to produce inflammatory pain
2006 StandoutNatureNobel
Sarcoidosis
2007 Standout
Disorders Associated with Antibodies to Endothelial Cells
1989
Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion
1997
Serum Angiotensin Converting Enzyme in Sarcoidosis—Its Value in Present Clinical Practice
1989
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Complement recruitment using bispecific diabodies
1997 StandoutNobel
Renin-angiotensin system: biochemistry and mechanisms of action.
1977 Standout
Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.
1989
Selection and characterization of bovine aortic endothelial cells
1978
The history of inhibitors of angiotensin converting enzyme
2001 Nobel
Formation of angiotensin III by angiotensin-converting enzyme
1976
Calculated Absorption and Scattering Properties of Gold Nanoparticles of Different Size, Shape, and Composition:  Applications in Biological Imaging and Biomedicine
2006 Standout
Angiotensin I‐converting Enzyme
1986
Comparison of the T lymphocyte-dependent induction of angiotensin-converting enzyme and leucine aminopeptidase in cultured human monocytes
1991
Low Endotoxic Potential ofLegionella pneumophilaLipopolysaccharide due to Failure of Interaction with the Monocyte Lipopolysaccharide Receptor CD14
1998
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
2001 StandoutNobel
Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo
2007 StandoutNobel
Complement Activation during Cardiopulmonary Bypass
1981 Standout
Nucleosome Arcs and Helices
1978 StandoutScienceNobel
The effect of particle design on cellular internalization pathways
2008 Standout
Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence
1976
Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.
1977
Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction.
1994
The classical pathway is the dominant complement pathway required for innate immunity toStreptococcus pneumoniaeinfection in mice
2002
Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture.
1990
Serum angiotensin-converting enzyme. Isolation and relationship to the pulmonary enzyme.
1977
Review: Mechanisms of action of gold
1981
Biomaterial-Centered Infection: Microbial Adhesion Versus Tissue Integration
1987 StandoutScience
Immunoisolation and partial characterization of endothelial plasmalemmal vesicles (caveolae).
1997 Nobel
Elevated serum neopterin levels in sarcoidosis
1986
The Design and Properties of N‐Carboxyalkyldipeptide Inhibitors of Angiotensin‐Converting Enzyme
1985
Is Cytosolic Ionized Calcium Regulating Neutrophil Activation?
1983 StandoutScienceNobel
Cross-linking of DNA with trimethylpsoralen is a probe for chromatin structure
1977 StandoutNobel
Angiotensin-converting enzyme and male fertility
1998 StandoutNobel
Mouse angiotensin-converting enzyme is a protein composed of two homologous domains
1989
A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease
2003 StandoutNobel
The isolation of angiotensin-converting enzyme cDNA.
1988
Lipopolysaccharide Endotoxins
2002 Standout
Structural repeating units in chromatin
1976
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
1987 Standout
Antiarthritic Gold Compounds Effectively Quench Electronically Excited Singlet Oxygen
1987 StandoutScienceNobel
The Biochemistry of the Renin-Angiotensin System
1980
Angiotensin-Converting Enzyme Gene Mutations, Blood Pressures, and Cardiovascular Homeostasis
1997 StandoutNobel
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
HORMONAL CONTROL OF LYSOSOMAL ENZYME RELEASE FROM HUMAN NEUTROPHILS
1974 StandoutNobel
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.
1977
Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
1990 Standout
Captopril in primary pulmonary hypertension.
1983
BIOCHEMISTRY OF INSECT VENOMS
1982
Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.
1987 StandoutNobel
Angiotensin‐converting enzyme activity in tissues of the rainbow trout
1984
THE CAVEOLAE MEMBRANE SYSTEM
1998 Standout
Metabolic Activity of Pulmonary Endothelium: Modulations of Structure and Function
1986
Mechanisms of Lysosomal Enzyme Release from Human Leukocytes: Microtubule Assembly and Membrane Fusion Induced by a Component of Complement
1973

Works of D. R. Schultz being referenced

C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids
1991
Antibody-independent binding of complement component C1q by Legionella pneumophila
1995
Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II)
1975
The first component of human complement: on the mechanism of activation by some carbohydrates.
1981
Isolation and partial characterization of a polysaccharide in ant venom (Pseudomyrmex sp.) that activates the classical complement pathway
1979
The separation of nine components and two inactivators of components of component in human serum
1970
Immunologic relationship among fibrinolysins secreted by cultured mammalian tumor cells
1975
Role of C1q in phagocytosis of Salmonella minnesota by pulmonary endothelial cells
1989
Characteristics of fibrinolysin secreted by cultured rat breast carcinoma cells
1975
Receptor-mediated binding of C1q on pulmonary endothelial cells
1986
Localization of angiotensin converting enzyme (kininase II). I. Preparation of antibody-heme-octapeptide conjugates
1976
Legionella pneumophila lipopolysaccharide activates the classical complement pathway
1992
Inactivation of C1 in rheumatoid synovial fluid, purfied C1 and C1 esterase, by gold compounds.
1974
Rankless by CCL
2026